Next, we analyzed the effects of BCL11B in combination with TCF1 on prognosis, compared with those who were TCF1highBCL11Bhigh, CLL patients who were TCF1lowBCL11Blow had a poorer TTFT and OS (Figures 4D, E, left panel) as well as shorter RMST (Figures 4D, E, right panel). Here, TCF7 is linked to B-cell chronic lymphocytic leukemia.